Aisling Capital Management’s Zosano Pharma Corporation ZSAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-77,663
| Closed | -$24K | – | 18 |
|
|
2022
Q2 | $24K | Sell |
77,663
-1
| -0% | -$2 | 0.02% | 18 |
|
|
2022
Q1 | $612K | Hold |
77,664
| – | – | 0.33% | 19 |
|
|
2021
Q4 | $1.28M | Hold |
77,664
| – | – | 0.45% | 18 |
|
|
2021
Q3 | $1.96M | Hold |
77,664
| – | – | 0.39% | 20 |
|
|
2021
Q2 | $2.58M | Hold |
77,664
| – | – | 0.41% | 20 |
|
|
2021
Q1 | $3.37M | Hold |
77,664
| – | – | 0.61% | 14 |
|
|
2020
Q4 | $1.43M | Hold |
77,664
| – | – | 0.25% | 15 |
|
|
2020
Q3 | $4.4M | Hold |
77,664
| – | – | 1.41% | 10 |
|
|
2020
Q2 | $2.33M | Hold |
77,664
| – | – | 0.89% | 10 |
|
|
2020
Q1 | $1.53M | Hold |
77,664
| – | – | 0.67% | 12 |
|
|
2019
Q4 | $4.13M | Buy |
77,664
+19,705
| +34% | +$1.22M | 1.58% | 8 |
|
|
2019
Q3 | $3.17M | Hold |
57,959
| – | – | 1.65% | 10 |
|
|
2019
Q2 | $6.63M | Buy |
57,959
+12,245
| +27% | +$1.45M | 2.83% | 9 |
|
|
2019
Q1 | $7.63M | Hold |
45,714
| – | – | 5.81% | 8 |
|
|
2018
Q4 | $3.39M | Buy |
+45,714
| New | +$5.79M | 3.57% | 10 |
|
Aisling Capital Management's ZSAN Position: Q3 2022 in Review
Aisling Capital Management sold out of Zosano Pharma Corporation (ZSAN) in Q3 2022, closing a stake of 77,663 shares — an estimated $24K sold.
Aisling Capital Management first reported a position in ZSAN in Q4 2018 and held it in 15 quarters. The position peaked at $7.63M in Q1 2019. 1 fund tracked by Wall St. Rank holds ZSAN as of Q3 2022.
- Aisling Capital Management reported no remaining Zosano Pharma Corporation position as of Q3 2022 after selling out during the quarter.
- Aisling Capital Management sold 77,663 Zosano Pharma Corporation shares in Q3 2022, an estimated $24K.
- Aisling Capital Management first reported a position in Zosano Pharma Corporation in Q4 2018 and held it in 15 quarters.
- Aisling Capital Management's Zosano Pharma Corporation position peaked at $7.63M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2022.
Based on Aisling Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.